¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"visual field for color"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cell color ratio
    ÀûÇ÷±¸»ö¼Òºñ
  • oxidizing color
    »êÈ­¿°·á
  • red color sign
    Àû»ö¡ÈÄ
  • subtractive color process
    °¨»ö°úÁ¤
  • binocular visual acuity
    ¾ç¾È½Ã·Â, µÎ´«½Ã·Â
  • complex visual discrimination
    º¹Çսð¢ºÐº°
  • central visual acuity
    Á߽ɽ÷Â
  • organic visual loss
    ±âÁú½Ã°¢»ó½Ç
  • stereoscopic visual acuity
    ÀÔü½Ã·Â
  • visual
    ½Ã·Â-, ½Ã°¢-
  • visual acuity
    ½Ã·Â
  • visual acuity test
    ½Ã·Â°Ë»ç
  • visual acuity test chart
    ½Ã·Â°Ë»çÇ¥
  • visual agnosia
    ½Ã°¢ÀνĺҴÉ(Áõ), ½Ã°¢½ÇÀÎÁõ
  • visual analogue scale
    ½Ã°¢¾Æ³¯·Î±×ôµµ, ½Ã°¢ÅëÁõµî±Þ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • color flow mapping
    »öÇ÷·ùÁöµµÈ­
  • color form sorting test
    »öäÇüÅÂÃ߸®±â°Ë»ç
  • color vision defect
    »ö°¢°áÇÔ
  • complementary color
    º¸»ö
  • coupling color
    Ä¿Çøµ¿°·á
  • oxidizing color
    »êÈ­¿°·á
  • protective color
    º¸È£»ö
  • subtractive color process
    °¨»ö°úÁ¤
  • red color sign
    Àû»ö¡ÈÄ
  • binocular visual acuity
    ¾ç¾È½Ã·Â, µÎ´«½Ã·Â
  • central visual acuity
    Á߽ɽ÷Â
  • stereoscopic visual acuity
    ÀÔü½Ã·Â
  • visual acuity
    ½Ã·Â
  • visual agnosia
    ½Ã°¢ÀνĺҴÉÁõ
  • visual angle
    ½Ã°¢°¢
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • rectangular field of view (FOV)
    Á÷»ç°¢Çü ½Ã¾ß
  • relative field
    ºñ±³¿µ¿ª(ÝïÎòçÐæ´).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • color doppler echocardiography
    »ö䵵Ǯ·¯½ÉÃÊÀ½ÆÄ°Ë»ç.
  • color doppler echocardiography
    »öä µµÇ÷¯ ½ÉÃÊÀ½ÆÄ °Ë»ç
  • color doppler flow mapping
    »ö (ßä) µµÇ÷¯ Ç÷·ùÇ¥½Ã (úì×µøúãÆ)
  • color flow imaging
    »ö Ç÷·ù ¿µ»ó
  • color flow imaging
    »öÇ÷·ù ¿µ»ó (ßäúì×µ ç±ßÀ)
  • color flow mapping
    »ö Ç÷·ù ÁöµµÈ­
  • color form sorting test
    »öäÇüÅÂ(ßäóôû¡÷¾)Ã߸®±â °Ë»ç(ËþÞÛ)
  • color fusion
    »öÀ¶ÇÕ
  • color mapping
    »öÁ¶ ÁöµµÈ­
  • color matching
    »ö¦Áþ±â
  • color mixing
    »öÈ¥ÇÕ
  • color naming
    »öÀ̸§´ë±â, »ö¸íȣĪ
  • color perception
    »ö°¢
  • color perimetry
    »ö½Ã¾ßÃøÁ¤(¹ý)
  • color pixel
    »ö È­¼Ò
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • field survey
    ÇöÁöÁ¶»ç
  • FOV [=field of view]
    ¿µ»ó¿µ¿ª, ¿µ»ó¹üÀ§
  • fringe field
    ÁÖº¯¾ß
  • fringe magnetic field strength
    ÁÖº¯ÀÚÀå¼¼±â
  • geometric field distortion artifact
    ±âÇÏÇÐÀûÀÚÀå¿Ö°îÀΰø¹°
  • gradient magnetic field
    °æ»çÀÚ±âÀå
  • high field MR scanner
    °íÀÚÀå ÀÚ±â°ø¸í½ºÄ³³Ê
  • horizontal field magnet
    ¼öÆò¸éÀÚ¼®
  • in-field-of-view saturation band
    ¿µ»ó¿µ¿ª³»Æ÷È­´ë
  • intermediate field MR scanner
    ÁßµîÀÚÀå ÀÚ±â°ø¸í½ºÄ³³Ê
  • irradiation field
    ¹æ»ç¼±Á¶»ç¾ß
  • low field MR scanner
    ÀúÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • lung field
    Æó¾ß
  • magnet field homogeneity
    ÀÚÀå±ÕÁú¼º
  • magnetic field
    ÀÚ(±â)Àå
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CVF cardiovascular failure; central visual field; cervicovaginal fluid; cobra venom factor
LVF left ventricular failure; left ventricular function; left visual field; low-voltage fast; low-voltag...
PVF peripheral visual field; portal venous flow; primary ventricular fibrillation
RVF renal vascular failure; Rift Valley fever; right ventricular failure; right visual field
VF left leg [electrode]; ventricular fibrillation; ventricular fluid; ventricular flutter; visual field...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CDI Color Doppler Imaging
CDU Color Doppler Ultrasound
CDS Color Doppler sonography
CDUS Color Doppler ultrasonography
CDUS Color Doppler ultrasound
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • field echo
    ÀÚÀå ¿¡ÄÚ
  • field inhomogeneity
    ÀÚÀå ºÒ±ÕÀÏ, ÀÚÀå ºÒ±ÕÀϼº
  • field profile
    ÀÚÀå Ãø¸é »ó
  • field strength
    ÀÚÀå ¼¼±â, ÀÚÀå·Â
  • field survey
    ÇöÁö Á¶»ç
  • fringe field
    ÁÖº¯ ¾ß
  • fringe magnetic field strength
    ÁÖº¯ ÀÚÀå ¼¼±â
  • intermediate field MR scanner
    Áßµî ÀÚÀå Àڱ⠰ø¸í ½ºÄ³³Ê
  • irradiation field
    Á¶»ç ¾ß
  • magnet field homogeneity
    ÀÚÀå ±ÕÁú¼º
  • magnetic field gradient
    ÀÚÀå °æ»ç
  • magnetic field intensity
    ÀÚÀå °­µµ
  • magnetic fringe field
    ÀÚ±â ÁÖº¯ ÀÚÀå
  • main magnetic field inhomogenity
    ÁÖÀÚÀå ºñ±ÕÁú¼º
  • mastication field
    ÀúÀÛ ¿ª
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
visual threshold Threshold of visual sensation, the minimal light intensity evoking a visual sensation.
Synonym: achromatic threshold, minimum light threshold.
(05 Mar 2000)
visual violet A visual pigment, composed of 11-cis-retinal bound to an opsin, found in the cones of the retina.
Synonym: visual violet.
Origin: G. Ion, violet, + ops, eye, + -in
(05 Mar 2000)
visual yellow The orange retinaldehyde resulting from the action of light on the rhodopsin of the retina, which converts the 11-cis-retinal component of the rhodopsin to all-trans-retinal plus opsin.
Synonym: trans-retinal, visual yellow.
(05 Mar 2000)
primary visual area Area of the occipital lobe concerned with vision.
(12 Dec 1998)
primary visual cortex See: visual cortex.
(05 Mar 2000)
secondary visual area Area of the occipital lobe concerned with vision.
(12 Dec 1998)
secondary visual cortex See: visual cortex.
(05 Mar 2000)
evoked potentials, visual The electric response evoked in the cerebral cortex by visual stimulation or stimulation of the visual pathways.
(12 Dec 1998)
unformed visual hallucination Hallucination composed of sparks, lights, or bursting spheres of light.
(05 Mar 2000)
formed visual hallucination <psychiatry> Hallucination composed of scenes, often landscapes.
(05 Mar 2000)
functional visual loss An apparent loss of visual acuity or visual field with no substantiating physical signs; often due to a natural concern about visual loss combined with suggestibility and a fear of the worst; best treated with reassurance.
(05 Mar 2000)
auditory field The space included within the limits of hearing of a definite sound, as of a tuning fork.
(05 Mar 2000)
bright field illumination <microscopy> The method of lighting the specimen with a solid cone of rays. Transmitted bright field illumination is performed by a substage condenser. Reflected bright field illumination is performed by a vertical illuminator.
Compare: dark field illumination
(05 Aug 1998)
bright field imaging <microscopy> An imaging mode in a transmission electron microscopy that uses only unscattered Electrons to form the image. Contrast in such an image is due entirely to mass-thickness variations in amorphous samples, and may include diffraction contrast in crystalline samples.
(05 Aug 1998)
bright field microscopy <technique> Optical microscopy, in which absorption to a great extent and diffraction to a minor extent give rise to the image, as opposed to phase contrast or interference methods of microscopy.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • color prejudice
    À¯»öÀÎÁ¾(ÈæÀÎ)¿¡ ´ëÇÑ
  • color print
    ¿ø»ö ÆÇÈ­;õ¿¬»ö ÀÎÈ­
  • color printing
    ¿ø»ö Àμâ;Ä÷¯ÀÎÈ­
  • color scheme
    (½Ç³» Àå½Ä.º¹½Ä µîÀÇ)»öäÀÇ ¹èÇÕ(¼³°è)
  • color separation
    »öºÐÇØ
  • color sergeant
    ±º±â È£À§ ÇÏ»ç°ü
  • color signal
    »ö½ÅÈ£
  • color supplement
    (½Å¹® µîÀÇ)Ä÷¯ÆÇ ºÎ·Ï
  • color television (TV)
    Ä÷¯ ÅÚ·¹ºñÀü ¹æ¼Û(¼ö»ó±â)
  • color temperature
    »ö¿Âµµ
  • color wash
    ¼ö¼º ÆäÀÎÆ®
  • color-bearer
    (±º´ëÀÇ)±â¼ö
  • color-blind
    »ö¸ÍÀÇ;ÀÎÁ¾ Â÷º°À» ÇÏÁö ¾Ê´Â
  • color-breed
    ƯÁ¤ÇÑ »öÀ» ³»µµ·Ï(ǰÁ¾À»)°³·®ÇÏ´Ù
  • color-code
    (Àü¼±.¼öµµ µîÀ»)(¾Ë±â ½±°Ô)»öÄ¥ÇÏ¿© ±¸ºÐÇÏ´Ù
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á